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Abstract
Hypertrophic  cardiomyopathy's  (HCM)  association  with  sudden  cardiac  death  is  well 
recognised. The risk of sudden cardiac death is known to increase when there is a history of 
unexplained  syncope,  abnormal  blood  pressure  response  during  exercise,  severe  left 
ventricular hypertrophy or a family history of unexplained death.                               
Implantable Cardioverter Defibrillator (ICD) implantation has been widely used for primary 
and secondary prevention of sudden cardiac death (SCD) in people with HCM. Subcutaneous 
ICD (S-ICD) therapy has been developed to overcome some of the problems associated with 
the transvenous leads used in conventional  ICDs.                                        
In this article, we report the use of S-ICD in a patient with HCM and multiple risk factors for 
sudden cardiac death, this device had to be extracted due to recurrent inappropriate shocks 
caused by over sensing of atrial flutter and failure to treat a VT episode. We are not aware of 
any reports  of  inappropriate  shocks caused by atrial  flutter  in  people with  a  S-ICD.     
Case  Details                                            
An 18 years old male was referred to the regional cardiac centre following admission to a 
peripheral  hospital  with  exertional  syncope  during  weight  lifting  exercises.  He  had  no 
significant past medical history and he was not taking any regular medication. There was a 
history of sudden cardiac death in his family.                                               
The  patient's  resting electrocardiogram had shown features  consistent  with  left  ventricular 
hypertrophy and repolarisation abnormalities (Figure 1).    
His full blood count, kidney function and inflammatory markers were all normal.                   
Echocardiography was performed, and the findings were consistent with a HCM phenotype 
with interventricular septal hypertrophy in excess of 3cms. Stress testing demonstrated a good 
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exercise capacity but an absolute absence of systolic blood pressure increase. In view of the 
patient's risk factors for SCD he was counselled with regards to the benefits of ICD therapy. 
Due to his young age and concerns about the potential for complications during long term 
endovascular device therapy a subcutaneous Cameron Health ® ICD (S-ICD) was advised and 
implanted under general anaesthesia.                           
Figure 1: Resting 12 lead ECG demonstrating large amplitude p waves indicating atrial enlargement particularly  
in  the  precordial  leads                                                      
In preparation for the implant  the patient  underwent  assessment  of his  surface ECG QRS 
morphology as per Cameron Health's recommended protocol to guard against over sensing of 
T waves and under sensing. The patient was discharged home on beta blockade and the device 
set  with a VF detection zone of 240bpm.                                                 
The  patient  was  re-admitted  to  hospital  one  month  following  implantation,  because  of  a 
conscious  shock from the  device.  This  had  been associated  with  presyncope.  The  logged 
arrhythmia  downloaded  from  the  device  demonstrated  atrial  flutter  (Figure  2).  Device 
interrogation  demonstrated  three  episodes  of  flutter  in  total,  only  one  of  which  received 
inappropriate shock therapy. The conscious shock was attributed to the over sensing of flutter 
waves as short RR intervals.
An  attempt  was  made  to  perform  a  flutter  ablation  during  this  admission,  this  was  not 
successful because it was not possible to produce cavo-tricuspid isthmus bidirectional block. 
The device was re-programmed and the setting was changed a VF zone at >250 beats per 
minute. The patient was loaded with oral amiodarone in addition to the pre existing bisoprolol 
prescription.
He was re-admitted to hospital three months later following an S-ICD discharge; this occurred 
without  any  preceding  symptoms.  Interrogation  of  the  device  demonstrated  four  logged 
episodes in the VF zone, three of which were atrial flutter associated with over sensing of 
flutter waves, the fourth episodes demonstrated over sensing of both P waves and T waves 
whist in sinus rhythm (Figure 3) The device sensing configuration was changed from the 
primary vector to the secondary vector in an attempt to eliminate the over sensing in sinus 
rhythm that was felt to be positional. 
Echocardiography done a month before admission had shown HCM with massive bi-atrial 
enlargement and pulmonary hypertension (Figure 4). On review of previous echocardiograms 
this had been present previously.
The patient was referred to the national HCM clinic and it was advised that the device should 
be changed for an endovascular device. It was decided not to attempt a further flutter ablation.
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Figure 2: S-ICD downloads demonstrating 'over sensing' of atrial flutter
Figure 3: Demonstrating oversensing of P and T waves resulting in an inappropriate shock therapy
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Figure 4: Echocardiogram in follow up demonstrating bi atrial enlargement
The patient was admitted for a fourth time following syncope and a subsequent conscious ICD 
shock. Device interrogation for logged events showed episodes of polymorphic VT (Figure 5) 
and atrial flutter. The polymorphic VT had been undetected and not treated. The shock had 
been delivered once again in response to over sensing of a flutter wave.
Figure 5: Polymorphic VT on device download
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During this  admission S-ICD was explanted and implanted with conventional  ICD.       
Discussion
Implantable  cardioverter  defibrillator  (ICD)  has  been  considered  useful  and  effective  in 
prevention  of  fatal  ventricular  arrhythmias.                                          
Conventional  transvenous  ICDs  have  been  observed  to  have  short  and  long  term 
complications.  These  include  cardiac  perforation,  haemothorax  and  pneumothorax  during 
implantation, lead displacement and failure, system erosion and lead prosthetic endocarditis. 
The S-ICD has been developed to overcome these disadvantages of conventional ICD therapy 
where anti tachy pacing, brady pacing or resynchronisation is not required.                  
Previous clinical trials on S-ICD therapy have shown that it is equal or better in comparison to 
transvenous ICD with regards to efficacy and safety [1]. We are not aware of any previous 
reports  regarding  inappropriate  shocks  secondary  to  atrial  flutter  by  an  S-ICD.          
The START study [2] compared the ability of S-ICD with single chamber and dual chamber 
transvenous  ICD  to  sense  arrhythmias  induced  during  programmed  electrophysiological 
testing  in  64  patients.  This  demonstrated  that  the  S-ICD  specificity  in  discriminating 
supraventricular arrhythmias was superior to transvenous systems (98.0% vs. 68.0% p<0.001).
Small follow up studies have shown inappropriate therapy rates of between 3 -13 % [4,5].   
The EFFORTLESS S-ICD registry continues to collect data on real world experience of S-
ICD therapy and has reported a 7 % incidence of inappropriate therapies in a cohort of 369 
patients during a five year follow up period. Over sensing (62%) was found to be the most 
common cause  of  inappropriate  shocks.                                                
This compares favourably to the MADIT II trial which reported 11.5% of 719 transvenous 
ICD patients had one or more inappropriate shocks. Most commonly this was secondary to 
atrial fibrillation (44%) or supraventricular tachycardia (36%). One fifth was attributed to T 
wave over sensing. The EFFORTLESS S-ICD registry is not obligatory. The Praetorian [3] 
study will further clarify the role of S-ICD therapy as a potential alternative to transvenous 
ICDs.
We have presented a case of inappropriate therapy for over sensing in both sinus rhythm and 
atrial flutter. The device did not treat an episode of polymorphic VT; however it is important 
to consider that this rhythm was self terminating and a traditional ICD programmed as per the 
MADIT-RIT  [8]  parameters  similarly  would  avoided  delivering  a  shock.
Conclusion
The wish to avoid endovascular  device therapy in patients with little  need for pacing and 
especially in the young remains compelling and we believe S-ICD remains a viable option in 
such patients. In this case our patient had a particularly challenging cardiac anatomy with huge 
atrial  enlargement  that  was  evident  on  his  resting  12  lead  ECG.  In  such  cases  with 
electrocardiographic evidence of atrial enlargement implanters should consider the potential 
for over sensing atrial arrhythmias in addition to the standard 'morphology assessment'.      
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